Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001553338-25-000005
Filing Date
2025-12-23
Accepted
2025-12-23 18:01:44
Documents
1
Period of Report
2025-12-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1766530901.html 4  
1 FORM 4 wk-form4_1766530901.xml 4 8138
  Complete submission text file 0001553338-25-000005.txt   9926
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Issuer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CALITHERA BIOSCIENCES 343 OYSTER POINT BLVD, SUITE 200 SO. SAN FRANCISCO CA 94080
Business Address
Waddill William D. (Reporting) CIK: 0001553338 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38042 | Film No.: 251601974